Navigation Links
GW researcher receives grant to answer the how and why of autism during development
Date:7/25/2014

WASHINGTON (July 24, 2014)The link between autism and disrupted brain development is an essential part of the puzzle of the disease, and is largely unknown. However, thanks to funding from the Simons Foundation Autism Research Initiative (SFARI), George Washington University (GW) researcher Anthony-Samuel LaMantia, Ph.D. may be able to offer truly integrative and in-depth answers to these key questions in the field of autism research.

LaMantia, professor of pharmacology and physiology at the GW School of Medicine and Health Sciences (SMHS), was awarded $739K from SFARI for his promising research on a key class of nerve cells found in the cerebral cortex, which is the part of the brain that performs many key functions disrupted in autism, particularly social interaction, communication, and cognition.

SFARI is a leading funder of autism research in the U.S. The prestigious SFARI research grants support cutting edge research at several research institutions. The SFARI research grant received by LaMantia and colleagues is the first such award at GW.

LaMantia and his research team, which includes interdisciplinary collaborators from GW and the University of Pennsylvania School of Medicine, will first look at how these nerve cells are generated from cortical stem cells during prenatal development. They will then look at connections made between these nerve cells in one cortical area with nerve cells in other cortical areas. The connections between these nerve cells have been suggested to be either diminished or increased based on imaging studies in patients with autism spectrum disorders (ASD). There is no clear indication, however, what cortical neurons make the abnormal connections, and whether under- or over-connectivity is related to autism pathology.

"Everybody agrees that sometime during development, the way the cerebral cortex is wired gets disrupted in autistic patients and that this is a key reason for the difficulties in behavioral regulation that these patients encounter," said LaMantia. "But no one really knows how that happens and what the end point is. We have the capacity to actually work out a key part of that question in a valid animal model."

The research team has found a valid animal model with a genetic mutation highly associated with autism. Over the next three years, they will use a combination of genetic techniques that allow the developmental history of neurons in the cortex to be traced, anatomical techniques that allow the number of connections made by these neurons to be defined, and electrophysiological techniques that assess the capacity of these neurons to receive, process, and relay information. Critically, LaMantia and colleagues will also be able to evaluate behaviors related to autism in the same animals, giving insight into the relationship between development, connectivity, and behavioral pathology in ASD.

"This funding gives GW real credibility as an institution that is doing serious autism research," said LaMantia. "We have a truly integrative group that can look at the developmental, cellular, biological, behavioral, and physiological issues of the question of under versus over connectivity which remains a central issue in clinical ASD research and how it arises during development. We are pleased to have the opportunity to answer these questions."


'/>"/>

Contact: Lisa Anderson
lisama2@gwu.edu
202-270-4841
George Washington University
Source:Eurekalert

Related biology news :

1. University of Houston researcher publishes textbook on tissue engineering
2. Whitehead Institute researchers create naïve pluripotent human embryonic stem cells
3. UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies
4. York University researchers use bird backpacks to put wood thrushes migration on the map
5. Intestinal parasites are old friends, researchers argue
6. UNH NHAES researchers work to save endangered New England cottontail
7. Researchers create vaccine for dust-mite allergies
8. Cleveland Clinic researchers discover neuroprotective role of immune cell
9. Researchers provide guide to household water conservation
10. UCI researchers find epigenetic tie to neuropsychiatric disorders
11. International Space Station researcher guides aim to maximize science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC ... today announced the opening of an IoT Center of ... strengthen and expand the development of embedded iris biometric ... unprecedented level of convenience and security with unmatched biometric ... one,s identity aside from DNA. EyeLock,s platform uses video ...
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016  The Prostate Cancer Foundation (PCF) is pleased to announce ... cures for prostate cancer. Members of the Class of 2016 were selected from ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
Breaking Biology Technology: